US FDA grants orphan Drug and rare pediatric disease designations to GEn1E lifesciences’ dual signal modulator for the treatment of Duchenne Muscular Dystrophy Business Wire (Press Release) 7h Business Wire (Press Release) 7h
Gilead and Merck announce positive topline results from two Phase 3 studies evaluating islatravir/lenacapavir, an oral once-weekly HIV treatment Business Wire (Press Release) 21h Business Wire (Press Release) 21h
Savara announces chief financial and administrative officer transition Business Wire (Press Release) 1d Business Wire (Press Release) 1d
Spruce Biosciences announces long-term tralesinidase alfa enzyme Replacement therapy data in Sanfilippo Syndrome Type B (MPS IIIB) presented at the 18th International MPS Symposium Business Wire (Press Release) 1d Business Wire (Press Release) 1d
The Netherlands is screening foreign investment in AI companies from January, after letting Nexperia slip through The Next Web 17:59
Abionyx Pharma : Combined Annual Shareholders’ Meeting on June 30, 2026: Availability of preparatory documents and procedures for participation and voting Business Wire (Press Release) 17:04
GSK Agrees to Acquire Nuvalent for $10.6 Billion in Major Oncology Deal, Sending Shares Soaring 39% International Business Times - AU Edition 15:18